Standard BioTools Inc (NASDAQ:LAB) shares, rose in value on Friday, November 01, with the stock price up by 1.28% to the previous day’s close as strong demand from buyers drove the stock to $1.99.
Actively observing the price movement in the recent trading, the stock is buoying the session at $1.96, falling within a range of $1.96 and $2.12. The value of beta (5-year monthly) is 1.576. Referring to stock’s 52-week performance, its high was $3.04, and the low was $1.21. On the whole, LAB has fluctuated by 9.67% over the past month.
With the market capitalization of Standard BioTools Inc currently standing at about $736.74 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 171.2M, with a low estimate of 42.2M and a high estimate of 44.6M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 43.03M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that LAB’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of LAB currently trading nearly 8.46% and 3.07% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 59.27, while the 7-day volatility ratio is showing 9.27% which for the 30-day chart, stands at 5.82%. Furthermore, Standard BioTools Inc (LAB)’s beta value is 1.57, and its average true range (ATR) is 0.13.
A comparison of Standard BioTools Inc (LAB) with its peers suggests the former has fared considerably weaker in the market. LAB showed an intraday change of 1.28% in today’s session so far, and over the past year, it grew by 1.28%%.
Data on historical trading for Standard BioTools Inc (NASDAQ:LAB) indicates that the trading volumes over the past 10 days have averaged 2.43 and over the past 3 months, they’ve averaged 2.17 million. According to company’s latest data on outstanding shares, there are 371.15 million shares outstanding.
Nearly 3.24% of Standard BioTools Inc’s shares belong to company insiders and institutional investors own 72.56% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 21.33 million shares as on 2024-10-15, resulting in a short ratio of 16.02. According to the data, the short interest in Standard BioTools Inc (LAB) stood at 1184.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 22.25 million. The stock has fallen by -10.18% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LAB stock heading into the next quarter.
